Health Catalyst, Inc.

NASDAQ:HCAT

Medical - Healthcare Information Services

Healthcare
$1.29 -1.98%

-$0.04 today

Market cap
$98.24M
Beta
1.66
P/E (TTM)
-0.5
EPS (TTM)
-$3.65
52W Low $0.96High $4.13

Volume 0.27M

Average 1.24M

HCAT Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

Health Catalyst, Inc.NASDAQ: HCAT

Net Debt · Q1 FY2026 · quarter ended Mar 2026

Net debt rises 83.3% from a year ago

Net debt stood at $110.71M at the end of Q1 FY2026, up 83.3% from a year earlier and down 8.1% from the prior quarter. Over 3 fiscal years it compounded at -2.9% a year.

Context

  • Net debt amounted to 26.9% of total assets at the end of Q1 FY2026, up 20.1 pp from a year earlier.
  • Net debt increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether net debt keeps rising in the next quarterly balance sheet after a +83.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$110.71M-8.1% QoQ
Last fiscal yearDec 2025
$120.42M-21.1% YoY
Year agoMar 2025
$60.4M+83.3% since
Net Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+83.3%——
1 year-21.1%——
3-year CAGR-2.9%——
5-year CAGR——
10-year CAGR——

Net Debt history

USD · from the balance sheet

Latest · FY2025
120.42M USD
Year-over-year change
-21.1%
4-year CAGR
+80.3%

Net Debt vs competitors

How HCAT compares with its peers on the latest reported figures

  • HCAT's Mar 2026 net debt of $110.71M is the 2nd highest of the 11 companies compared; the peer median is $8.14M.
  • Its year-over-year change of +83.3% is the 4th highest of 11, against a peer median of +26.4%.
  • Net debt amounts to 26.9% of total assets for HCAT, versus a peer median of 21.3%.
HCAT Competitors Peer median
Net Debt for HCAT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ENTAEnanta Pharmaceuticals, Inc.Mar 2026$151.69M -2.7%—48.2%
HCATHealth Catalyst, Inc.Mar 2026$110.71M +83.3%-2.9%26.9%
OMOutset Medical, Inc.Mar 2026$71.05M +219.5%+30.2%28.5%
CRBUCaribou Biosciences, Inc.Mar 2026$14.89M +566.3%—10.0%
SNWVSANUWAVE Health, Inc.Mar 2026$11.39M -38.0%-33.7%30.7%
PYXSPyxis Oncology, Inc.Mar 2026$11.02M +55.6%—17.1%
OBIOOrchestra BioMed Holdings, Inc.Mar 2026$5.27M +376.7%—5.2%
PRLDPrelude Therapeutics IncorporatedMar 2026-$4.04M +81.9%—3.4%
HSDTSolana CompanyMar 2026-$4.4M -296.3%—2.2%
NNOXNano-X Imaging Ltd.Dec 2025-$41.3M -29.6%—25.5%
TNYATenaya Therapeutics, Inc.Mar 2026-$70.77M -73.2%—52.4%
Peer median (excluding HCAT) $8.14M+26.4%-1.8%21.3%

Competitors are the stored peer set for HCAT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents193.23M116.31M106.28M249.65M50.81M
Short-term Investments251.75M247.18M211.45M142.36M44.92M
Net Receivables48.8M47.97M60.29M57.18M59.13M
Inventory00000
Other Current Assets14.61M16.34M15.38M16.47M14.45M
Total Current Assets508.39M427.8M393.4M465.65M169.31M
Property, Plant & Equipment (Net)44.45M42.59M39.64M41.45M40.48M
Goodwill169.97M185.98M190.65M259.76M209.07M
Intangible Assets104.79M92.19M73.38M86.05M77.68M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets4.5M3.73M4.74M6.02M6.11M
Total Non-current Assets323.71M324.49M308.42M393.28M333.34M
Total Assets832.1M752.29M701.81M858.93M502.64M
Account Payables4.69M4.42M6.64M11.43M9.36M
Short-term Debt000231.18M1.63M
Tax Payables00000
Deferred Revenue56.63M54.96M55.75M53.28M56.11M
Other Current Liabilities10.87M7.51M11.68M11.66M5.2M
Total Current Liabilities93.05M82.51M89.03M325.85M89.57M
Long-term Debt180.94M226.52M228.03M151.18M151.62M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)929K105K77K249K410K
Other Non-current Liabilities14.83M121K74K154K798K
Total Non-current Liabilities216.95M244.77M245.86M167.87M167.29M
Total Liabilities310M327.28M334.9M493.72M256.86M
Common Stock53K1.42B1.48B1.55B1.61B
Retained Earnings(878.86M)(999.02M)(1.12B)(1.19B)(1.36B)
Accumulated OCI(67K)(648K)33K(835K)1.59M
Other Stockholders Equity00000
Minority Interest00000
Total Equity522.1M425.01M366.92M365.21M245.78M
Total Debt204.61M247.97M249.07M402.27M171.24M
Net Debt11.38M131.66M142.79M152.62M120.42M

Health Catalyst, Inc.

NASDAQ:HCAT

Intrinsic Alpha fair value

Locked

Current Price

$1.29

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.